Physician's Briefing
Conference Coverage
About
Lymphoma
Physician’s Briefing
FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma
Lori Solomon
15 Dec 2025
1 min read
Physician’s Briefing
FDA Approves Expanded Indication for Jaypirca
Lori Solomon
09 Dec 2025
1 min read
Physician’s Briefing
ASH: Lifestyle Intervention Feasible During Chemo for Lymphoma
Elana Gotkine
09 Dec 2025
2 min read
Read More
Cookie Settings
Clinical Briefing Report
clinicalbriefingreport.com
INSTALL APP
